Robeco Institutional Asset Management B.V. raised its holdings in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 18.1% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 604,339 shares of the company’s stock after purchasing an additional 92,646 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Kimberly-Clark were worth $85,985,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently bought and sold shares of KMB. William B. Walkup & Associates Inc. acquired a new stake in shares of Kimberly-Clark in the 2nd quarter valued at $26,000. New Millennium Group LLC bought a new stake in shares of Kimberly-Clark in the 2nd quarter valued at about $28,000. Crewe Advisors LLC bought a new stake in shares of Kimberly-Clark in the 1st quarter valued at about $27,000. DiNuzzo Private Wealth Inc. increased its stake in shares of Kimberly-Clark by 808.0% in the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company’s stock valued at $32,000 after acquiring an additional 202 shares during the last quarter. Finally, ORG Wealth Partners LLC bought a new stake in shares of Kimberly-Clark in the 3rd quarter valued at about $39,000. Institutional investors own 76.29% of the company’s stock.
Kimberly-Clark Trading Down 0.6 %
Shares of Kimberly-Clark stock opened at $133.74 on Tuesday. The business has a fifty day simple moving average of $141.79 and a two-hundred day simple moving average of $139.25. Kimberly-Clark Co. has a 1 year low of $117.67 and a 1 year high of $149.30. The company has a market capitalization of $44.60 billion, a price-to-earnings ratio of 17.35, a P/E/G ratio of 2.82 and a beta of 0.40. The company has a debt-to-equity ratio of 4.77, a current ratio of 0.83 and a quick ratio of 0.55.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the company. TD Cowen initiated coverage on Kimberly-Clark in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price target for the company. UBS Group lowered their target price on Kimberly-Clark from $153.00 to $151.00 and set a “neutral” rating for the company in a research note on Wednesday, October 23rd. StockNews.com cut Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 30th. Piper Sandler increased their target price on Kimberly-Clark from $167.00 to $174.00 and gave the stock an “overweight” rating in a research note on Thursday, July 11th. Finally, Argus raised Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $149.93.
View Our Latest Stock Analysis on Kimberly-Clark
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More
- Five stocks we like better than Kimberly-Clark
- How to Invest in the Best Canadian Stocks
- Intel: Is Now the Time to Be Brave?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is a support level?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.